Research Projects
Selective blockade of the IL6/STAT3/SMG1 pathway in multiresistant circulating tumor cells (CTCs) as a pathway of sensitization to oncoimmunotherapy
Researcher | Principal Investigator
Aptamers Research Group
Research Division
Technological Innovation Division
Research group
Aptamers
Project information
Research project "Selective blockade of the IL6/STAT3/SMG1 pathway in multiresistant circulating tumor cells (CTCs) as a pathway for sensitization to oncoimmunotherapy: a new possibility for cancer immunotherapy" of the Aptamer research group of Cima University of Navarra.
- Convocation: AES Proyectos de Investigación
- Reference: PI23/01120
- Start date: January 1, 2024
- End date: December 31, 2026
- Funder: Instituto de Salud Carlos III
- Nature of project: National
- Award year 2023
Need more information?
If you are interested in learning more about our research, please contact us.